Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFevertree Regulatory News (FEVR)

Share Price Information for Fevertree (FEVR)

Share Price is delayed by 15 minutes
Get Live Data
807.00    -22.00 (-2.65%)
Bid:
812.00
Ask:
815.50
Spread: 3.50 (0.431%)
Market Cap: £918.95m
FEVR Live PriceLast checked at - London Stock Exchange

Intraday Fevertree Share Chart

Director/PDMR Shareholding

16 Aug 2019 12:55

RNS Number : 3630J
Fevertree Drinks PLC
16 August 2019
Β 

Fevertree Drinks plc

Β ("Fever-Tree" or the "Company")

Β 

Director/PDMR Shareholding

Fever-Tree, the world's leading supplier of premium carbonated mixers, announces that on 15 August 2019, Jeff Popkin, a Non-Executive Director of the Company, bought 2,000 ordinary shares in the Company at price of $26.24 per ordinary share via US OTC markets.

Β 

For further information:

Β 

Fevertree Drinks plc

Tim Warrillow, Co-founder and CEO

Andy Branchflower, Finance Director

Oliver Winters, Communications & IR Director

+44 (0)20 7349 4922

Numis Securities - Nominated Adviser and Joint Broker

Garry Levin

Matt Lewis

Hugo Rubinstein

Β 

Investec Bank plc - Joint Broker

David Flin

Alex Wright

David Anderson

+44 (0)20 7260 1000

Β 

Β 

Β 

+44 (0)20 7597 5970

Brunswick Group

+44 (0) 207 404 5959

Jonathan Glass fevertree@brunswickgroup.com

Fiona Micallef-Eynaud

Kate Pope

Β 

Notes to Editors:

Β 

Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to over 70 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company now sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On Trade") as well as selected retail outlets ("Off Trade").

Β 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them in accordance with the Market Abuse Regulations

Β 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Jeff Popkin

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Fevertree Drinks plc

Β 

b)

LEI

2138007AJRLHRVQZLD07

Β 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Fever-Tree equity trading OTC as FQVTF

Β 

Β 

Β 

GB00BRJ9BJ26

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Β 

Price(s)

Volume(s)

1.

$26.24

2,000

d)

Aggregated information

Β 

n/a single trade

e)

Date of the transaction

15 August 2019

f)

Place of the transaction

US OTC market

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
DSHBBGDIGXBBGCL
Date   Source Headline
30th Apr 20257:00 amRNSTransaction in Own Shares
29th Apr 20257:00 amRNSTransaction in Own Shares
28th Apr 20257:00 amRNSTransaction in Own Shares
25th Apr 20257:00 amRNSTransaction in Own Shares
24th Apr 202512:30 pmRNSAnnual Report and Notice of AGM
24th Apr 20257:00 amRNSTransaction in Own Shares
23rd Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 202510:53 amRNSHolding(s) in Company
22nd Apr 20257:00 amRNSTransaction in Own Shares
17th Apr 20257:00 amRNSTransaction in Own Shares
16th Apr 20257:00 amRNSTransaction in Own Shares
15th Apr 20257:00 amRNSTransaction in Own Shares
14th Apr 20257:00 amRNSUpdate on share buyback extension
14th Apr 20257:00 amRNSTransaction in Own Shares
11th Apr 20257:00 amRNSTransaction in Own Shares
10th Apr 20257:00 amRNSTransaction in Own Shares
9th Apr 20257:00 amRNSTransaction in Own Shares
8th Apr 20257:00 amRNSTransaction in Own Shares
7th Apr 20257:00 amRNSTransaction in Own Shares
4th Apr 20257:00 amRNSTransaction in Own Shares
3rd Apr 20257:00 amRNSTransaction in Own Shares
2nd Apr 20257:00 amRNSTransaction in Own Shares
1st Apr 20257:00 amRNSTotal Voting Rights
1st Apr 20257:00 amRNSTransaction in Own Shares
31st Mar 20257:00 amRNSTransaction in Own Shares
28th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSFY24 Preliminary Results to 31 December 2024
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 20257:00 amRNSTransaction in Own Shares
17th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20257:00 amRNSTransaction in Own Shares
10th Mar 20257:00 amRNSTransaction in Own Shares
7th Mar 20257:00 amRNSTransaction in Own Shares
5th Mar 20257:00 amRNSTransaction in Own Shares
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 202512:00 pmRNSTotal Voting Rights
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20257:00 amRNSTransaction in Own Shares
26th Feb 20257:00 amRNSTransaction in Own Shares
25th Feb 20257:00 amRNSTransaction in Own Shares
24th Feb 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.